DD55956A - - Google Patents
Info
- Publication number
- DD55956A DD55956A DD55956DA DD55956A DD 55956 A DD55956 A DD 55956A DD 55956D A DD55956D A DD 55956DA DD 55956 A DD55956 A DD 55956A
- Authority
- DD
- German Democratic Republic
Links
Publications (1)
Publication Number | Publication Date |
---|---|
DD55956A true DD55956A (zh) |
Family
ID=251922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DD55956D DD55956A (zh) |
Country Status (1)
Country | Link |
---|---|
DD (1) | DD55956A (zh) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0302132A1 (de) * | 1987-01-27 | 1989-02-08 | Deutsche Hydrierwerke GmbH Rodleben | Verfahren und Vorrichtung zur Herstellung von 5-Methyl-7-diethylamino-s-triazolo(1,5-a)-pyrimidin |
WO2002002563A2 (en) * | 2000-06-30 | 2002-01-10 | Wyeth | Substituted-triazolopyrimidines as anticancer agents |
WO2004108136A1 (en) * | 2003-06-04 | 2004-12-16 | Vernalis (Cambridge) Limited | Triazolo `1 , 5-a!pyrimidines and their use in medicine |
WO2005025315A1 (en) * | 2003-09-12 | 2005-03-24 | Basf Aktiengesellschaft | 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
-
0
- DD DD55956D patent/DD55956A/xx unknown
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0302132A1 (de) * | 1987-01-27 | 1989-02-08 | Deutsche Hydrierwerke GmbH Rodleben | Verfahren und Vorrichtung zur Herstellung von 5-Methyl-7-diethylamino-s-triazolo(1,5-a)-pyrimidin |
WO2002002563A2 (en) * | 2000-06-30 | 2002-01-10 | Wyeth | Substituted-triazolopyrimidines as anticancer agents |
WO2002002563A3 (en) * | 2000-06-30 | 2003-01-03 | Wyeth Corp | Substituted-triazolopyrimidines as anticancer agents |
AU2001273062B2 (en) * | 2000-06-30 | 2005-11-24 | Wyeth | Substituted-triazolopyrimidines as anticancer agents |
WO2004108136A1 (en) * | 2003-06-04 | 2004-12-16 | Vernalis (Cambridge) Limited | Triazolo `1 , 5-a!pyrimidines and their use in medicine |
WO2005025315A1 (en) * | 2003-09-12 | 2005-03-24 | Basf Aktiengesellschaft | 6-halogeno-[1,2,4]triazolo[1,5-a]pyrimidines for combating animal pests |
EA010091B1 (ru) * | 2003-09-12 | 2008-06-30 | Басф Акциенгезельшафт | 6-ГАЛОГЕНО[1,2,4]ТРИАЗОЛО[1,5-a]ПИРИМИДИНЫ ДЛЯ БОРЬБЫ С ВРЕДИТЕЛЯМИ |
AU2004271715B2 (en) * | 2003-09-12 | 2010-08-26 | Basf Aktiengesellschaft | 6-halogeno-(1,2,4)triazolo(1,5-a)pyrimidines for combating animal pests |
EP2392567A1 (en) | 2005-10-21 | 2011-12-07 | Bristol-Myers Squibb Company | Benzothiazine derivatives and their use as lxr modulators |
WO2007062314A2 (en) | 2005-11-23 | 2007-05-31 | Bristol-Myers Squibb Company | Heterocyclic cetp inhibitors |
WO2008070496A2 (en) | 2006-12-01 | 2008-06-12 | Bristol-Myers Squibb Company | N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001273062B2 (en) | Substituted-triazolopyrimidines as anticancer agents | |
AU2001273062A1 (en) | Substituted-triazolopyrimidines as anticancer agents | |
US20070275961A1 (en) | Triazolo ' 1, 5-A ! Pyrimidines and Their Use in Medicine | |
ZA200602965B (en) | 6-halogeno-[1,2,4]triazolo[1,5-A]pyrimidines for combating animal pests | |
DD55956A (zh) |